These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
434 related articles for article (PubMed ID: 15231735)
21. Tumor-promoting phorbol esters and activated Ras inactivate the tuberous sclerosis tumor suppressor complex via p90 ribosomal S6 kinase. Roux PP; Ballif BA; Anjum R; Gygi SP; Blenis J Proc Natl Acad Sci U S A; 2004 Sep; 101(37):13489-94. PubMed ID: 15342917 [TBL] [Abstract][Full Text] [Related]
22. Honokiol activates AMP-activated protein kinase in breast cancer cells via an LKB1-dependent pathway and inhibits breast carcinogenesis. Nagalingam A; Arbiser JL; Bonner MY; Saxena NK; Sharma D Breast Cancer Res; 2012 Feb; 14(1):R35. PubMed ID: 22353783 [TBL] [Abstract][Full Text] [Related]
23. Phosphorylation of tuberin as a novel mechanism for somatic inactivation of the tuberous sclerosis complex proteins in brain lesions. Han S; Santos TM; Puga A; Roy J; Thiele EA; McCollin M; Stemmer-Rachamimov A; Ramesh V Cancer Res; 2004 Feb; 64(3):812-6. PubMed ID: 14871804 [TBL] [Abstract][Full Text] [Related]
24. Loss of tuberous sclerosis complex-2 function and activation of mammalian target of rapamycin signaling in endometrial carcinoma. Lu KH; Wu W; Dave B; Slomovitz BM; Burke TW; Munsell MF; Broaddus RR; Walker CL Clin Cancer Res; 2008 May; 14(9):2543-50. PubMed ID: 18451215 [TBL] [Abstract][Full Text] [Related]
25. Functional analysis of Peutz-Jeghers mutations reveals that the LKB1 C-terminal region exerts a crucial role in regulating both the AMPK pathway and the cell polarity. Forcet C; Etienne-Manneville S; Gaude H; Fournier L; Debilly S; Salmi M; Baas A; Olschwang S; Clevers H; Billaud M Hum Mol Genet; 2005 May; 14(10):1283-92. PubMed ID: 15800014 [TBL] [Abstract][Full Text] [Related]
27. TSC2 integrates Wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3 to regulate cell growth. Inoki K; Ouyang H; Zhu T; Lindvall C; Wang Y; Zhang X; Yang Q; Bennett C; Harada Y; Stankunas K; Wang CY; He X; MacDougald OA; You M; Williams BO; Guan KL Cell; 2006 Sep; 126(5):955-68. PubMed ID: 16959574 [TBL] [Abstract][Full Text] [Related]
28. Inappropriate activation of the TSC/Rheb/mTOR/S6K cassette induces IRS1/2 depletion, insulin resistance, and cell survival deficiencies. Shah OJ; Wang Z; Hunter T Curr Biol; 2004 Sep; 14(18):1650-6. PubMed ID: 15380067 [TBL] [Abstract][Full Text] [Related]
29. Cell-type-dependent regulation of mTORC1 by REDD1 and the tumor suppressors TSC1/TSC2 and LKB1 in response to hypoxia. Wolff NC; Vega-Rubin-de-Celis S; Xie XJ; Castrillon DH; Kabbani W; Brugarolas J Mol Cell Biol; 2011 May; 31(9):1870-84. PubMed ID: 21383064 [TBL] [Abstract][Full Text] [Related]
31. Phosphorylation of the protein kinase mutated in Peutz-Jeghers cancer syndrome, LKB1/STK11, at Ser431 by p90(RSK) and cAMP-dependent protein kinase, but not its farnesylation at Cys(433), is essential for LKB1 to suppress cell vrowth. Sapkota GP; Kieloch A; Lizcano JM; Lain S; Arthur JS; Williams MR; Morrice N; Deak M; Alessi DR J Biol Chem; 2001 Jun; 276(22):19469-82. PubMed ID: 11297520 [TBL] [Abstract][Full Text] [Related]
32. mTOR and HIF-1alpha-mediated tumor metabolism in an LKB1 mouse model of Peutz-Jeghers syndrome. Shackelford DB; Vasquez DS; Corbeil J; Wu S; Leblanc M; Wu CL; Vera DR; Shaw RJ Proc Natl Acad Sci U S A; 2009 Jul; 106(27):11137-42. PubMed ID: 19541609 [TBL] [Abstract][Full Text] [Related]
33. Tuberous sclerosis: from tubers to mTOR. Kwiatkowski DJ Ann Hum Genet; 2003 Jan; 67(Pt 1):87-96. PubMed ID: 12556239 [TBL] [Abstract][Full Text] [Related]
34. Phosphorylation and functional inactivation of TSC2 by Erk implications for tuberous sclerosis and cancer pathogenesis. Ma L; Chen Z; Erdjument-Bromage H; Tempst P; Pandolfi PP Cell; 2005 Apr; 121(2):179-93. PubMed ID: 15851026 [TBL] [Abstract][Full Text] [Related]
35. mTORC1 enhancement of STIM1-mediated store-operated Ca2+ entry constrains tuberous sclerosis complex-related tumor development. Peng H; Liu J; Sun Q; Chen R; Wang Y; Duan J; Li C; Li B; Jing Y; Chen X; Mao Q; Xu KF; Walker CL; Li J; Wang J; Zhang H Oncogene; 2013 Sep; 32(39):4702-11. PubMed ID: 23108404 [TBL] [Abstract][Full Text] [Related]
36. Association of focal adhesion kinase with tuberous sclerosis complex 2 in the regulation of s6 kinase activation and cell growth. Gan B; Yoo Y; Guan JL J Biol Chem; 2006 Dec; 281(49):37321-9. PubMed ID: 17043358 [TBL] [Abstract][Full Text] [Related]
37. Induction of cyclooxygenase-2 in a mouse model of Peutz-Jeghers polyposis. Rossi DJ; Ylikorkala A; Korsisaari N; Salovaara R; Luukko K; Launonen V; Henkemeyer M; Ristimaki A; Aaltonen LA; Makela TP Proc Natl Acad Sci U S A; 2002 Sep; 99(19):12327-32. PubMed ID: 12218179 [TBL] [Abstract][Full Text] [Related]
38. Rhebbing up mTOR: new insights on TSC1 and TSC2, and the pathogenesis of tuberous sclerosis. Kwiatkowski DJ Cancer Biol Ther; 2003; 2(5):471-6. PubMed ID: 14614311 [TBL] [Abstract][Full Text] [Related]
39. LKB1 interacts with and phosphorylates PTEN: a functional link between two proteins involved in cancer predisposing syndromes. Mehenni H; Lin-Marq N; Buchet-Poyau K; Reymond A; Collart MA; Picard D; Antonarakis SE Hum Mol Genet; 2005 Aug; 14(15):2209-19. PubMed ID: 15987703 [TBL] [Abstract][Full Text] [Related]
40. EGFR activation confers protections against UV-induced apoptosis in cultured mouse skin dendritic cells. Cao C; Lu S; Jiang Q; Wang WJ; Song X; Kivlin R; Wallin B; Bagdasarian A; Tamakloe T; Chu WM; Marshall J; Kouttab N; Xu A; Wan Y Cell Signal; 2008 Oct; 20(10):1830-8. PubMed ID: 18644433 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]